Despite the proposal that TP53 mutations impact ovarian cancer recurrence in certain studies, in current study, the in-depth delineation of TP53 mutation and MDR1 copy number analysis permitted us to identify a new mechanism by which recurrence of ovarian cancer is accelerated through the evolution of chemoresistance due to TP53 mutation. This evidence concerns the gene TP53 and ovarian cancer.